UBS AM’s Aurora Cannabis ACB Stock Holding History

UBS AM’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,693	Closed	-$851K	–	2778
2021 Q4	$851K	Buy	+15,693	New	+$1.06M	﹤0.01%	2299

Other funds holding ACB

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS AM's ACB Position: Q1 2022 in Review

UBS AM sold out of Aurora Cannabis (ACB) in Q1 2022, closing a stake of 15,693 shares — an estimated $851K sold.

UBS AM first reported a position in ACB in Q4 2021 and held it in 1 quarter. The position peaked at $851K in Q4 2021. 253 funds tracked by Wall St. Rank hold ACB as of Q1 2022.

UBS AM reported no remaining Aurora Cannabis position as of Q1 2022 after selling out during the quarter.
UBS AM sold 15,693 Aurora Cannabis shares in Q1 2022, an estimated $851K.
UBS AM first reported a position in Aurora Cannabis in Q4 2021 and held it in 1 quarter.
UBS AM's Aurora Cannabis position peaked at $851K in Q4 2021.
253 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2022.

Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.